Ezetimibe +Atorvastatin
Tulip Combo is a medicine that lowers high cholesterol. Tulip Combo contains ezetimibe and atorvastatin.
Tulip Combo is used in adults to lower the level of total cholesterol, "bad" cholesterol (LDL) and fatty substances called triglycerides in the blood.
Additionally, Tulip Combo increases the level of "good" cholesterol (HDL).
Tulip Combo lowers cholesterol in two ways. It reduces the absorption of cholesterol in the gut and its production in the body.
Cholesterol is one of several fatty substances found in the blood. Total cholesterol is mainly made up of "bad" (LDL) and "good" (HDL) cholesterol.
LDL cholesterol is often called "bad" cholesterol because it can build up in the walls of arteries and form plaques. Over time, this plaque can lead to narrowing of the arteries. This narrowing can slow down or block the flow of blood to vital organs such as the heart and brain. Blocking the flow of blood can lead to a heart attack or stroke.
HDL cholesterol is often called "good" cholesterol because it helps prevent the buildup of "bad" cholesterol in the walls of arteries and prevents heart disease.
Triglycerides are other fats found in the blood that can increase the risk of heart disease.
A doctor may prescribe Tulip Combo if the patient is already taking atorvastatin and ezetimibe in the doses contained in this medicine, as an addition to a cholesterol-lowering diet in cases of:
Tulip Combo does not affect weight loss.
Before taking Tulip Combo, the patient should discuss with their doctor or pharmacist if:
muscle pain, tenderness or weakness while taking Tulip Combo.In rare cases, muscle problems can be serious, including muscle breakdown leading to kidney damage. It is known that atorvastatin causes muscle problems. Muscle problems have also been reported with ezetimibe.
If muscle weakness persists, the patient should tell their doctor or pharmacist. Additional tests may be needed to diagnose these problems and medication may be necessary.
Before taking Tulip Combo, the patient should consult their doctor or pharmacist:
If any of the above situations apply to the patient (or the patient is unsure), they should consult their doctor or pharmacist before taking Tulip Combo, as the doctor will need to perform a blood test before starting treatment and, if possible, during treatment, to assess the risk of muscle-related side effects. The risk of muscle-related side effects, such as rhabdomyolysis (breakdown of skeletal muscle), increases when taking certain medicines at the same time (see section 2 "Tulip Combo and other medicines").
During treatment, the doctor will closely monitor the patient's health if they have diabetes or are at risk of developing diabetes. The likelihood of developing diabetes is higher in people with high blood sugar and fat levels, overweight and high blood pressure.
The patient should inform their doctor about all their illnesses, including allergies.
Tulip Combo is not recommended for use in children and adolescents.
The patient should tell their doctor or pharmacist about all medicines they are taking, have recently taken or might take.
The patient should avoid taking Tulip Combo and fibrates (cholesterol-lowering medicines) at the same time.
There are several medicines that can affect the action of Tulip Combo or whose action may be affected by Tulip Combo (see section 3). This type of interaction can reduce the effectiveness of one or both medicines. It can also increase the risk or severity of side effects, including serious muscle damage, known as "rhabdomyolysis", described in section 4:
Other medicines that interact with the combination product:
See section 3 for information on how to take Tulip Combo. The patient should be aware of the following:
Grapefruit juice
The patient should not drink more than one or two small glasses of grapefruit juice per day, as larger amounts may affect the action of the combination medicine.
Alcohol
The patient should avoid drinking too much alcohol while taking this medicine. See section 2 "Warnings and precautions".
The patient should not take Tulip Combo if they are pregnant, plan to become pregnant or think they may be pregnant.
Tulip Combo should not be taken by women of childbearing age unless they use effective methods of contraception. If the patient becomes pregnant while taking Tulip Combo, they should stop taking the medicine immediately and inform their doctor.
The patient should not take Tulip Combo while breastfeeding.
If the patient is pregnant or breastfeeding, thinks they may be pregnant or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
The patient should not expect Tulip Combo to affect their ability to drive or use machines. However, the patient should bear in mind that some people may experience dizziness after taking Tulip Combo. If the patient experiences dizziness after taking this medicine, they should not drive or use machines.
If the patient has been diagnosed with an intolerance to some sugars, they should contact their doctor before taking the medicine.
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially "sodium-free".
The patient should always take this medicine exactly as their doctor has told them. The doctor will determine the dose of Tulip Combo that is right for the patient, depending on their current treatment and individual risk.
In case of doubt, the patient should consult their doctor or pharmacist.
How to take the medicine
The recommended dose of Tulip Combo is one tablet taken orally, once a day, preferably at the same time every day. The tablet should be swallowed with a sufficient amount of liquid (e.g. one glass of water).
When to take the medicine
Tulip Combo can be taken at any time of day, with or without food.
If the doctor has prescribed Tulip Combo and another cholesterol-lowering medicine containing cholestyramine or another bile acid sequestrant (cholesterol-lowering medicines), the patient should take Tulip Combo at least 2 hours before or 4 hours after taking the bile acid sequestrant.
The patient should contact their doctor or pharmacist.
If the patient misses a dose, they should not take a double dose to make up for the missed dose. The next tablet should be taken at the right time.
If the patient has any further questions on the use of this medicine, they should ask their doctor or pharmacist.
Like all medicines, Tulip Combo can cause side effects, although not everybody gets them.
The patient should consult their doctor as soon as possible if they experience unexpected or unusual bleeding or bruising, which may indicate liver problems.
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Frequency not known (cannot be estimated from the available data):
The patient should talk to their doctor if they experience weakness in their arms or legs, worsening after periods of activity, double vision or drooping eyelids, difficulty swallowing or shortness of breath.
Additionally, after the medicine has been on the market, the following side effects have been reported with the use of some statins (cholesterol-lowering medicines):
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw
tel.: + 48 22 49 21 301, fax: + 48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
The patient should not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the month.
The medicine should be stored in its original packaging. There are no special storage instructions.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer need. This will help protect the environment.
Tulip Combo, 10 mg + 10 mg
Each film-coated tablet contains 10 mg of ezetimibe (Ezetimibum) and 10 mg of atorvastatin (Atorvastatinum) in the form of atorvastatin calcium trihydrate.
Tulip Combo, 10 mg + 20 mg
Each tablet contains 10 mg of ezetimibe (Ezetimibum) and 20 mg of atorvastatin (Atorvastatinum) in the form of atorvastatin calcium trihydrate.
Tulip Combo, 10 mg + 40 mg
Each film-coated tablet contains 10 mg of ezetimibe (Ezetimibum) and 40 mg of atorvastatin (Atorvastatinum) in the form of atorvastatin calcium trihydrate.
Tulip Combo, 10 mg + 80 mg
Each film-coated tablet contains 10 mg of ezetimibe (Ezetimibum) and 80 mg of atorvastatin (Atorvastatinum) in the form of atorvastatin calcium trihydrate.
The other ingredients are: microcrystalline cellulose, mannitol, calcium carbonate, sodium croscarmellose, hydroxypropylcellulose, polysorbate 80, yellow iron oxide (E 172), magnesium stearate, povidone K29/32, sodium lauryl sulfate.
Tablet coating
Tulip Combo 10 mg + 10 mg, Tulip Combo 10 mg + 20 mg, Tulip Combo 10 mg + 40 mg, film-coated tablets
Opadry White OY-L28900:
Lactose monohydrate
Hypromellose 2910
Titanium dioxide (E 171)
Macrogol 4000
Tulip Combo 10 mg + 80 mg film-coated tablets
DrCoat FCU:
Hypromellose 2910
Titanium dioxide (E 171)
Talc (E553b)
Macrogol 400
Yellow iron oxide (E 172)
Tulip Combo, 10 mg + 10 mg
White, round, biconvex film-coated tablets with a diameter of about 8.1 mm.
Tulip Combo, 10 mg + 20 mg
White, oval, biconvex film-coated tablets with dimensions of about 11.6 mm x 7.1 mm.
Tulip Combo, 10 mg + 40 mg
White, biconvex film-coated tablets in the shape of a capsule, with dimensions of about 16.1 mm x 6.1 mm.
Tulip Combo, 10 mg + 80 mg
Yellow, elongated, biconvex film-coated tablets with dimensions of about 19.1 mm x 7.6 mm.
Blisters of OPA/Aluminum/PVC/Aluminum foil containing 30 film-coated tablets.
Perforated single-dose blisters of OPA/Aluminum/PVC/Aluminum foil containing 30 x 1 film-coated tablet.
Marketing authorization holder
Sandoz GmbH
Biochemiestrasse 10
6250 Kundl,
Austria
Manufacturer
Lek Pharmaceuticals d.d.
Verovškova 57
1526 Ljubljana, Slovenia
ELPEN Pharmaceutical Co. Inc.,
Marathonos Ave. 95, Pikermi Attiki,
19009, Greece
Hungary
Ezetimibe/Atorvastatin Sandoz 10 mg/40 mg filmtabletta
Ezetimibe/Atorvastatin Sandoz 10 mg/80 mg filmtabletta
Ezetimibe/Atorvastatin Sandoz 10 mg/10 mg filmtabletta
Ezetimibe/Atorvastatin Sandoz 10 mg/20 mg filmtabletta
Spain
Ezetimiba/Atorvastatina Sandoz 10 mg/10 mg comprimidos recubiertos con película
Ezetimiba/Atorvastatina Sandoz 10 mg/20 mg comprimidos recubiertos con película
Ezetimiba/Atorvastatina Sandoz 10 mg/40 mg comprimidos recubiertos con película
Ezetimiba/Atorvastatina Sandoz 10 mg/80 mg comprimidos recubiertos con película
Poland
Tulip Combo
Slovakia
Tulip Plus 10 mg/20 mg
Tulip Plus 10 mg/40 mg
Sandoz Polska Sp. z o.o.
ul. Domaniewska 50 C
02-672 Warsaw
tel. 22 209 70 00
Date of last revision of the leaflet:04/2023
Sandoz logo
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.